Our funders

NAM works hard to make sure it receives its income from a wide range of sources so it does not rely too heavily on any one funder. This includes individuals, trusts and foundations, companies, international agencies and government. This means we can be confident that our future will not be jeopardised by a funder unexpectedly withdrawing its support. It also affords us a great deal of scope to respond to needs rapidly as they arise or to undertake projects that could otherwise be restricted. But most importantly, it allows us to remain wholly independent and means that you can be confident that the information we produce will always be impartial, accurate and reliable.

For the same reason, we don’t accept any paid advertising on aidsmap.com or in any of NAM’s printed information materials. NAM receives no sponsorship for editorial content we provide about commercially available medical, scientific or other goods or services.

We are fortunate to receive some funds from the pharmaceutical industry, which has been generous in supporting community-based HIV treatment information work. Their support is long-standing and has provided security in a rapidly changing funding environment. However, we have strict funding guidelines in place to ensure the independence and impartiality of all our information. There is no question of their being able to interfere with our editorial stance or influence us in any other way that undermines our independence. The pharmaceutical companies understand and honour our position on this.

We would like to take this opportunity to thank all our donors, past and present, for their support. It is your commitment and generosity that underpins everything we achieve for people affected by HIV.

Donor

Work supported in 2016 and/or 2017 via grants and donations

Charitable trusts & foundations

Wandsworth Oasis

NAM’s patient information resources focusing on HIV and ageing (example shown here), starting treatment and pre-exposure prophylaxis (PrEP).

Conference organisers

Harm Reduction International

News coverage from the International Harm Reduction Conference in May 2017.

HIV Glasgow Organising Committee

News coverage from the HIV Glasgow conference in October 2016.

Government departments

UK Government’s Department of Health

Development of a new business model to ensure the continued delivery of patient information to England’s HIV clinics.

Multilateral agencies

UNAIDS

News coverage of progress towards UNAIDS’ 90-90-90 target.

Non-governmental organisations

AIDS Vaccine Advocacy Coalition (AVAC)

PrEP in Europe Initiative.

Medical Foundation for HIV & Sexual Health (MedFASH)

Continued publication of the Sexual Health & HIV Policy EURObulletin.

Pharmaceutical companies

Gilead Sciences

Printed edition of Antiretroviral drug chart; new interactive tool to assist people to report side-effects/symptoms to their doctor; The Vine project, which will see the development of a range of patient information resources to support people as they age and live long term with HIV (example here); infohep.org; post-conference feedback forum following the International AIDS Conference; distribution of patient information materials across Ireland.

Janssen-Cilag

Aidmap’s news coverage and patient information resources; infohep’s news coverage and background resources; development of patient information materials to support people as they age and live long term  with HIV; distribution of patient information materials to clinics with cohorts of fewer than 200.

Merck & Co

The Vine project, infohep’s hepatitis-focused news, news coverage of 2016’s International AIDS Conference and HIV Glasgow conference.

ViiV Healthcare

The Vine project, the continued publication of the Sexual Health & HIV Policy EURObulletin; PreP in Europe Initiative.

In addition to grants and donations NAM has been contracted, in 2016 and/or 2017, by various organisations to deliver specific services including:

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.